Cargando…
Cancer stem cells in neuroblastoma therapy resistance
Neuroblastoma (NB) is the most common cancer of infancy and accounts for nearly one tenth of pediatric cancer deaths. This mortality rate has been attributed to the > 50% frequency of relapse despite intensive, multimodal clinical therapy in patients with progressive NB. Given the disease’s heter...
Autores principales: | Aravindan, Natarajan, Jain, Drishti, Somasundaram, Dinesh Babu, Herman, Terence S., Aravindan, Sheeja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924637/ https://www.ncbi.nlm.nih.gov/pubmed/31867574 http://dx.doi.org/10.20517/cdr.2019.72 |
Ejemplares similares
-
MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution
por: Aravindan, Natarajan, et al.
Publicado: (2019) -
De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
por: Somasundaram, Dinesh Babu, et al.
Publicado: (2019) -
Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease
por: Ramraj, Satish Kumar, et al.
Publicado: (2016) -
Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells
por: Aravindan, Sheeja, et al.
Publicado: (2016) -
Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples
por: Somasundaram, Dinesh Babu, et al.
Publicado: (2019)